Poor Sleep Linked to 172 Diseases, Including Dementia, Parkinson’s, and Diabetes

Health & LifestyleNews
197

Listen to article (english)

Translate to Spanish or other 102 languages!

Researchers have found a link between sleep quality and disease risk with many chronic conditions. Image for illustration purposes
Researchers have found a link between sleep quality and disease risk with many chronic conditions. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today 

Getting enough quality sleep every night is important for good health, but the extent it affects overall health is still being researched. A new study has linked 172 different diseases, including dementia, diabetes, and Parkinson’s disease to poor sleep patterns. Of those diseases, 92 of them had over 20% of their risk correlated with poor sleep behavior.

Getting enough quality sleep every night is important for good health. However, some people may still be unclear about what “quality sleep” entails and what impact sleep really has on their health.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/poor-sleep-linked-172-diseases-dementia-parkinsons-type-2-diabetes?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-08-05&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Susan Monarez Sworn in as CDC Director
Next article
DHR Health’s Back-to-School Safety Tips

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -